The Fourth EORTC DCIS Consensus Meeting (Chateau Marquette, Heemskerk, The Netherlands, 23-24 January 1998) - Conference Report

European Journal of Cancer

Volumn 34, Issue 11, 1998, Pages 1664-1669

  Recht, A ^a   Rutgers, E J Th ^b   Fentiman, I S ^c   Kurtz, J M ^f   Mansel, R E ^d   Sloane, J P ^e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c GUY S HOSPITAL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CANCER; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGISTRY; CARCINOMA IN SITU; CONFERENCE PAPER; HEALTH CARE QUALITY; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; PATIENT SELECTION; RISK FACTORS;

EID: 0032190186     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00220-2     Document Type: Conference Paper

References (42)

1. 1. Van Dongen JA, Fentiman IS, Harris JR, et al. In-situ breast cancer: the EORTC consensus meeting. Lancet 1989, 2, 25-27.
2. 2. Van Dongen JA, Holland R, Peterse JL, et al. Ductal carcinoma in-situ of the breast: second EORTC consensus meeting. Eur J Cancer 1992, 28A, 626-629.
3. 3. Recht A, van Dongen JA, Fentiman IS, Holland R, Lagios MD, Peterse JL. Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994) - conference report. Eur J Cancer 1994, 30A, 1895-1901.
4. 4. Haagensen CD. Diseases of the Breast. Philadelphia, W.B. Saunders, 1956.
5. 5. Bodian CA, Perzin KH, Lattes R. Lobular neoplasia: long term risk of breast cancer and relation to other factors. Cancer 1996, 78, 1024-1034.
6. 6. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 1993, 17, 14-21.
7. 7. Fisher ER, Constantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer 1996, 78, 1403-1416.
8. 8. Tavassoli FA. Mammary intraepithelial neoplasia: a transitional classification system for the intraductal epithelial proliferations. Breast J 1997, 3, 48-58.
9. 9. Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of histologic type of the in situ component with grade of the infiltrating component. Semin Diagn Pathol 1994, 11, 215-222.
10. 10. Gupta SK, Douglas-Jones AG, Fenn N, Morgan JM, Mansel RE. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer 1997, 80, 1740-1745.
11. 11. Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR 1992, 159, 483-485.
12. 12. Holland R, Hendriks JHCL. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 1994, 11, 181-192.
13. 13. Ciatto S, Rosselli Del Turco M, Bravetti P. Nonpalpable breast lesions: stereotaxic fine-needle aspiration cytology. Radiology 1989, 173, 57-59.
14. 14. Cariaggi MP, Bulgaresi P, Confortini M, et al. Analysis of the causes of false negative cytology reports on breast cancer fine needle aspirates. Cytopathology 1995, 6, 156-161.
15. 15. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotactic core biopsy of breast lesions: an indication for surgical biopsy. AJR 1995, 164, 1111-1113.
16. 16. Liberman L, Dershaw DD, Rosen PP, et al. Stereotactic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 1995, 194, 379-381.
17. 17. Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Schurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1992, 335, 519-522.
18. 18. Faverly DRG, Burgers L, Bult P, Holland R. Three-dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994, 11, 193-198.
19. 19. Gilles R, Zafrani B, Guinebretière JM, et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995, 196, 415-419.
20. 20. Soderstrom CE, Harms SE, Copit DS, et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996, 201, 427-432.
21. 21. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR imaging of ductal carcinoma in situ. Radiology 1997, 202, 413-420.
22. 22. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998, 16, 441-452.
23. 23. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996, 77, 2267-2274.
24. 24. Silverstein MJ. Van Nuys prognostic index. In Silverstein MJ, Lagios MD, Poller DN, et al., eds. Ductal Carcinoma In Situ of the Breast. Baltimore, William & Wilkins, 1997, 491-501.
25. 25. Solin L, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996, 14, 754-763.
26. 26. Solin LJ, Haffty B, Fourquet A, et al. An international collaborative study: a 15-year experience. In Silverstein MJ, Lagios MD, Poller DN, et al., eds. Ductal Carcinoma In Situ of the Breast. Baltimore, William & Wilkins, 1997, 385-390.
27. 27. Cataliotti L, Disante V, Ciatto S, et al. Intraductal breast cancer: review of 183 consecutive cases. Eur J Cancer 1992, 28A, 917-920.
28. 28. Cataliotti L, Distante V, Pacini P, et al. Florence experience. In Silverstein MJ, Lagios MD, Poller DN, Recht A, eds. Ductal Carcinoma In Situ of the Breast. Baltimore, William & Wilkins, 1997, 449-454.
29. 29. Hetelekidas S, Collins L, Schnitt SJ, et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ (Abstr.). Int J Radiat Oncol Biol Phys 1997, 39(Suppl.), 138.
30. 30. Hiramatsu H, Bornstein B, Recht A, et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in-situ: the possible importance of family history. Cancer J Sci Am 1995, 1, 55-61.
31. 31. Bornstein BA, Harris JR, Hetelekidas S, Hiramatsu H, Recht A. Joint Center for Radiation Therapy experience. In Silverstein MJ, Lagios MD, Poller DN, et al., eds. Ductal Carcinoma In Situ of the Breast. Baltimore, William & Wilkins, 1997, 399-403.
32. 32. Schwartz GF. Sub-clinical ductal carcinoma in situ of the breast: selection by local excision and surveillance alone. Breast J 1996, 2, 41-44.
33. 33. Schwartz GR. Treatment of subclinical ductal carcinoma in situ by local excision and surveillance: a personal experience. In Silverstein MJ, Lagios MD, Poller DN, et al., eds. Ductal Carcinoma In Situ of the Breast. Baltimore, William & Wilkins, 1997, 353-360.
34. 34. Sibbering DM, Pinder SE, Obuszko Z, et al. Local excision with a 10mm margin as sole treatment for ductal carcinoma in situ (DCIS) of the breast (Abstr.). Eur J Cancer 1996, 32A(Suppl. 2), 24.
35. 35. Sibbering DM, Blamey RW. Nottingham experience. In Silverstein MJ, Lagios MD, Poller DN, et al., eds. Ductal Carcinoma In Situ of the Breast. Baltimore, William & Wilkins, 1997, 367-372.
36. 36. Whelan TJ, Levine MN, Gafni A, et al. Breast irradiation postlumpectomy: development and evaluation of a decision instrument. J Clin Oncol 1995, 13, 847-853.
37. 37. Palda VA, Llewellyn-Thomas HA, Mackenzie RG, Pritchard KI, Naylor CD. Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making. J Clin Oncol 1997, 15, 3192-3200.
38. 38. Hayman JA, Fairclough DL, Harris JR, Weeks JC. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 1997, 15, 1252-1260.
39. 39. Silverstein MJ, Lagios M, Lewinsky BS, et al. Breast irradiation is unnecessary for widely excised ductal carcinoma in situ (DCIS) (Abstr.). Breast Cancer Res Treat 1997, 46, 23.
40. 40. Arnesson L-G, Smeds S, Fagerberg G, Grontoft O. Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br J Surg 1989, 76, 672-675.
41. 41. Fourquet A, Zafrani B, Campana F, Clough KB. Institut Curie experience. In Silverstein MJ, Lagios MD, Poller DN, et al., eds. Ductal Carcinoma In Situ of the Breast. Baltimore, William & Wilkins, 1997, 391-397.
42. 42. Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997, 80, 1798-1802.